[ad_1]
Comply with
Retired historical past teacher. Alzheimer’s illness researcher for the previous 20 years.My purpose is to present traders strong recommendation based mostly on the mechanisms of motion of Alzheimer’s medicine. This recommendation is knowledgeable by a background in biology (conservation, ecology, evolution, environmental science, and biochemistry) and twenty years of a really in depth assessment of the analysis on Alzheimer’s illness. I’ve come to the conclusion that Alzheimer’s illness is attributable to oxidation and nitration. Many therapies for Alzheimer’s illness tackle components that may contribute to oxidation and nitration corresponding to misfolded amyloid and tau proteins and neuroinflammation, however only a few direct scavenge compounds (corresponding to hydrogen peroxide and peroxynitrite) that trigger oxidation and nitration nor do they reverse any of the injury already current. Thus, most therapies for Alzheimer’s illness solely decelerate the early development of the illness for awhile. Sure pure merchandise corresponding to panax ginseng and varied important oils by way of aromatherapy inhibit oxidation and nitration, scavenge brokers that trigger oxidative and nitrostative stress, and reverse a part of their injury. Such therapies have the potential to stabilize Alzheimer’s illness.I observe corporations, corresponding to Anavex and Cyclo Therapeutics, whose drug candidate could do the identical. These are the one Alzheimer’s corporations that I like to recommend investing in.
Analyst’s Disclosure: I/now we have no inventory, possibility or related by-product place in any of the businesses talked about, and no plans to provoke any such positions throughout the subsequent 72 hours. I wrote this text myself, and it expresses my very own opinions. I’m not receiving compensation for it (apart from from Searching for Alpha). I’ve no enterprise relationship with any firm whose inventory is talked about on this article.
Searching for Alpha’s Disclosure: Previous efficiency is not any assure of future outcomes. No suggestion or recommendation is being given as as to whether any funding is appropriate for a specific investor. Any views or opinions expressed above could not mirror these of Searching for Alpha as an entire. Searching for Alpha isn’t a licensed securities supplier, dealer or US funding adviser or funding financial institution. Our analysts are third occasion authors that embrace each skilled traders and particular person traders who might not be licensed or licensed by any institute or regulatory physique.
[ad_2]
Source link
